Survival benefit of boron neutron capture therapy for recurrent malignant gliomas
Authors:
- Shin-Ichi MiyatakeSMShin-Ichi Miyatake
- Shinji KawabataSKShinji Kawabata
- Kunio YokoyamaKYKunio Yokoyama
- Toshihiko KuroiwaTKToshihiko Kuroiwa
- Hiroyuki MichiueHMHiroyuki Michiue
- Yoshinori SakuraiYSYoshinori Sakurai
- Hiroaki KumadaHKHiroaki Kumada
- Minoru SuzukiMSMinoru Suzuki
- Akira MaruhashiAMAkira Maruhashi
- Mitsunori KirihataMKMitsunori Kirihata
- Koji OnocKOKoji Onoc
- 1 July 2009
- journal article
- clinical trial
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 67 (7-8) , S22-S24
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- An investigation of boron neutron capture therapy for recurrent glioblastoma multiformeActa Neurologica Scandinavica, 2008
- Prognostic Factors for Survival in Adult Patients With Recurrent Glioma Enrolled Onto the New Approaches to Brain Tumor Therapy CNS Consortium Phase I and II Clinical TrialsJournal of Clinical Oncology, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseAnnals of Oncology, 2001
- Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical TrialsJournal of Clinical Oncology, 1999